Navigation Links
Studies review smoking among college freshmen and tobacco use by adolescents with ADHD
Date:12/3/2007

arch and Intervention.


Reduced-Exposure Tobacco Products

The use of tobacco products that have the potential to reduce exposure to tobacco toxicants is a controversial issue among scientists, policy makers, advocacy groups and health professionals. This controversy reflects, in part, the experience of low-tar, low-nicotine tobacco products introduced in the 1970s, which initially seemed to hold promise for reducing tobacco harm but instead were based on misleading claims that may have led to a negative public health impact.

After dramatic decreases in the prevalence of tobacco use that were observed over the past decades, the rate of quitting smoking has slowed, leading scientists to debate whether the remaining smokers tend to be hardened or hard-core smokers. Of the 22 million smokers who tried to quit, approximately 3-5% are successful for at least one year and at any one time, only 4-20% are seriously thinking of quitting smoking within the next month.

Not starting to smoke and quitting smoking are still the best ways to avoid the harm from tobacco. But for current smokers, this paper also suggests that the tobacco industry must be regulated: a) to avoid misleading consumers about the safety of products ( e.g., by labeling them as light or ultra-light or reduced exposure to carcinogens) , b) to prevent the initiation of tobacco use among children and adolescents (e.g., by adding flavors to cigarettes that encourage experimentation ) ; c) to be sure that smokers who would otherwise have quit do not maintain tobacco use (e.g., through the marketing of smokeless tobacco as a substitute to cigarettes in smoke-free locations); and d) to stop the continued manufacturing of extremely toxic products when the technology to manufacture less toxic products is available.

Title of Paper: Developing the Science Base for Reducing Tobacco Harm. Lead author: Dorothy K. Hatsukami, Ph.D., University of Minnesota, Transd
'/>"/>

Contact: Prabhu Ponkshe
prabhu@healthmatrixinc.com
703-918-4860
Health Matrix, Inc.
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Gene Studies of Male-Female Differences Often Flawed
2. Two studies published in the Lancet
3. Study of Studies Finds No Risk to Children From Phthalates in Toys
4. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
5. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
6. Studies Prove Exercise Can Heal the Body Mind and Soul
7. Studies Shed New Light on Breast Cancer, Treatment
8. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
9. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...eyed MCO Pharmacy Directors Will Move Razadyne and...zadyne is Launched, According to a New ... Mass., July 9 /PRNewswire/ -- Decision Resources,...firms for pharmaceutical and,healthcare issues, fi.../Ortho McNeil,s Razadyne (galantamine) in December...
(Date:7/9/2008)...ve day OnBase deployment critical in electronic he...t patients, CLEVELAND, July 9 /PRNewswire/ -- Hyl...e document management software suite, announced th...ts since the deployment of,OnBase in March. Based ...ur,states, SSM is a forward-thinking health care p...
(Date:7/9/2008)..., July 9 /PRNewswire-FirstCall/ - MDS Inc. (TSX: M... services to the global life,sciences markets, tod...anada Limited (AECL) with notice of arbitration pr...AECL to fulfill its contractual obligations,under ...LTSA) and if not,granted, seeking significant mone...
(Date:7/9/2008)... DRE, Inc., a premier international ...ts customers that as much as $250,000 in medical e...e tax filings. , Louisvil...us Act of 2008, in accordance with Tax Code Sectio...equipment bought in 2008. This could make 2008 an ...
Breaking Medicine News(10 mins):Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 3Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 2Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...was launched here Saturday for providing assistanc... Social Service Foundation, a non-governmental o...pline, which will provide information about the ne...reatment facilities are available for children wit...
...against HIV/AIDS is becoming grimmer by the day. A...could be infected with HIV/AIDS by 2015 if the cu...rts have warned. "We should be winning in HIV pre...e president and director of HIV policy at the Kais...
...r from the University of Kalyani, India, has found...nger and produce more offspring if reared in dilut... Jana and his colleagues at the university, mixed ...he university's urinals and added the zooplankton ...
...moderate amount of alcohol may be good for your he...e University of Miami has shown that people who dr...rage health than light drinkers, heavy drinkers an...drank. However, it is not clear whether moderate...
Other Medicine News:Health News:Helpline Launched for Hearing Impaired 2Health News:Expand HIV/AIDS Prevention Programs, Experts Stress 2Health News:Expand HIV/AIDS Prevention Programs, Experts Stress 3Health News:Moderate Drinkers Outlive Their Teetotaler and Heavy Drinking Counterparts 2
(Date:7/7/2008)...lar Biometrics presents scientific evidence suppor...bolomics platform at major international ... and CHESTER, N.J., July 7 /- Molecul...company developing novel,clinical tools for applic...,characterize biologic function in health and dise...
(Date:7/7/2008)... New Study Suggests Kiwifruit is Top Performer in ... fruits are created equal when,it comes to their a...the,highest in bioavailability compared to other a...ll-scale study published in the Journal of the,Ame... vitamins and phytochemicals called flavonoids tha...
(Date:7/3/2008)...BRUNSWICK, N.J., July 3 /- ...any") (Amex: SNT ) announced today,that it has co...I") to,supply the plasmid portion of the Company,s...ene and siRNA against Factor 5A., Senesco has pre...lts,using its combination siRNA and plasmid agains...
(Date:7/1/2008)...sion of Five-Day Dosing Regimen sNDA Targeted for ...008, WOODCLIFF LAKE, N.J., July 1, 2008 /PRNewswi...nounced the preliminary efficacy data from a trial...e) to Best Supportive Care,(BSC) in elderly patien...did not demonstrate a statistically significant ad...
Breaking Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Kiwifruit: Antioxidant Power in Quantity and Quality 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4Freshman class sparks start up company 666 1Freshman class sparks start up company 666 2Differing attitudes found between women and doctors concerning menstrual suppression 2793 1Differing attitudes found between women and doctors concerning menstrual suppression 2793 2First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E Coli Contaminated Ground Beef 2791 1First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E Coli Contaminated Ground Beef 2791 2First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E Coli Contaminated Ground Beef 2791 3Inverness Medical Innovations Acquires Bio Stat Healthcare Group 2787 1Inverness Medical Innovations Acquires Bio Stat Healthcare Group 2787 2
...Apr 19, 2007 - Amgen,(NASDAQ: AMGN) today announce...uble-blind, placebo-controlled, multicenter Phase ...eviously untreated,patients with extensive-stage s...ntaining chemotherapy. The study demonstrated,no s...th (overall,survival Aranesp compared to placebo H...
...Apr 19, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB...rchers at Loma Linda University Medical Center,Na... University,showing that one of the Company,s meta...d protection of healthy normal cells in mice,with ...y. The study,also showed that the compound did not...
Other Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 2Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 3
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with particulate (silica) activator.
The ALB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of albumin in serum
For the quantitative in vitro determination of Total Protein in serum and plasma
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma.
Medicine Products: